Simon Panton
Follow
Get notifications in MyBN when activity occurs.
Simon Panton
Non-Executive Director / Resonance Health
Simon Panton has been a major shareholder of Resonance Health since 2008 and joined the board in 2009 as he is strong believer in liver health technologies. Mr Panton started and ran his own successful small business for over 15 years. He has experience in the property industry, financial markets, and the acquisition and disposal of investments. He currently manages assets and projects associated within family holdings and was a non-executive director of 4DS Ltd.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 536th | Proteomics International Laboratories | 8% | 26% |
| 628th | Resonance Health | 3% | -7% |
| 840th | HITIQ | -7% | |
| 1612th | Nuheara | -60% | -44% |
| 1835th | Emyria | -78% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 123rd |  | Resonance Health | $4.5m |
| 130th | | Emyria | $3.8m |
| 131st | | Nuheara | $3.8m |
| 135th |  | HITIQ | $3.2m |
| 136th | | Proteomics International Laboratories | $3.2m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| REMUNERATION UPDATE: Non-Executive Director, Resonance Health | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Resonance Health | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Resonance Health | 30 Jun 2020 |
